Recovery in Colgate-Palmolive Stock Could Be Short-Lived
Colgate-Palmolive (CL) stock outperformed the broader markets in November and increased 6.7%. Colgate-Palmolive’s top line is projected to remain low during the fourth quarter, which reflects the negative impact from currency rates and challenging market conditions in China and Brazil. Analysts expect Colgate-Palmolive’s fourth-quarter EPS to decline on a year-over-year basis due to lower sales and weak margins.